<insert self-management goal> Quick Reference Guide
Statin (if CVD, age ≥40 for type 2, OR diabetes complications) ASA (if CVD) SGLT2i/GLP1ra with demonstrated CV benefi t (if have ... Statin1 1 Dose adjustments or additional lipid therapy warranted if lipid target (LDL-C <2.0 mmol/L) not being met. 2 ACE-inhibitor or ARB (angiotensin receptor blocker) should be given at doses that have ...
Download <insert self-management goal> Quick Reference Guide
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
Canadian Journal of Diabetes
guidelines.diabetes.caindependence is lost and/or life expectancy shortens, the benefit of lower glycemic targets is diminished and the risk of hypoglyce-mia increases (40–42).
DiabetesCanadaClinicalPracticeGuidelinesExpertCommittee ...
guidelines.diabetes.caType2DiabetesinChildrenandAdolescents,p.S247 DiabetesandPregnancy,p.S255 Relevant Appendices Appendix 5. Self-Monitoring of Blood Glucose (SMBG) RecommendationToolforHealth-CareProviders
ÉTAPE 1 - guidelines.diabetes.ca
guidelines.diabetes.caSuggestions pour l’amorçage et le titrage de l’insuline dans les cas de diabète de type 2 Les personnes qui commencent à prendre de l’insuline doivent être renseignées sur la prévention, la reconnaissance et le traitement de l’hypoglycémie.
My Diabetes Care: Patient Name
guidelines.diabetes.caA1C The A1C is a blood test that will help you know whether your blood sugar has been at target over the past 3 months. A lower A1C will reduce your risk A lower A1C will reduce your risk of heart disease, stroke, kidney disease, eye problems, nerve damage, and foot problems.
High blood pressure and diabetes - guidelines.diabetes.ca
guidelines.diabetes.caWhy is controlling blood pressure important for people with diabetes? When blood pressure is high, it puts stress on the body. This can cause damage to the heart, brain, kidneys,
<insert self-management goal> Quick Reference Guide
guidelines.diabetes.caA1C <1.5% above target A1C ≥1.5% above target Symptomatic hyperglycemia and/or metabolic decompensation* Add additional antihyperglycemic agent best suited to the individual based on the following: Clinical Considerations Choice of Agent Avoidance of hypoglycemia and/or weight gain with adequate glycemic effi cacy
Pharmacologic Glycemic Management of Type 2 Diabetes in ...
guidelines.diabetes.ca2018 (1). New evidence has been published since the 2018 guide-lines, prompting this update to our recommendations for Chapter 13, “Pharmacologic Glycemic Management of Type 2 Diabetes in Adults” (1). What’s New in 2020 First, additional agents approved for use in Canada have been shown to have cardiovascular (CV) benefits in patients ...
Glycemic Index Food Guide - Diabetes Canada
guidelines.diabetes.caTry these meal planning ideas to lower meal GI: &RRN\RXUSDVWDDOGHQWH 4UP &KHFN\RXU pasta package instructions for cooking time. Make fruits and milk part of your meal plate (Figure 1). These foods often have a low GI and make a healthy dessert. Try lower GI grains, such as barley and bulgur. Pulses can be grains and starches or meat and
Glycemic Index Food Guide - Diabetes Canada
guidelines.diabetes.caThe glycemic index (GI) is a scale that ranks a carbohydrate-containing food or drink by how much it raises blood sugar levels after it is eaten or drank. Foods with a high GI increase blood sugar higher and faster than foods with a low GI. There are three GI categories:
Lows and highs: blood sugar levels - Diabetes Canada
guidelines.diabetes.caWhat is LOW blood sugar? When the amount of blood glucose (sugar in your blood) has dropped below your target range (less than 4 mmol/L), it is called low blood sugar or hypoglycemia. What are the signs of a LOW blood sugar level? You may feel: • Shaky, light-headed, nauseated • Nervous, irritable, anxious • Confused, unable to concentrate
Related documents
Major Recommendations for Statin Therapy for ...
www.mplsheart.comintensity statin if: LDL > 160 mg/dl, family history, hs CRP > 2, CAC>300 or 75%, ABI < .9, or high lifetime risk. Clinical atherosclerotic cardiovascular disease LDL-C ≥ 190 mg/dl Type 1 or 2 Diabetes age 40-75 Age 40-75 Estimated 10 yr atherosclerotic CVD risk > 7.5% High-Intensity Statin Daily dose lowers LDL-C by approx ≥ 50%
Table 5. Statin Dose Intensity and Equivalency Chart*
www.mqic.orgStatin Dose Intensity and Equivalency Chart* Statin Intensity %LDL-C Reduction HMG-CoA Reductase Inhibitor Rosuvastatin Atorvastatin Pitavastatin Simvastatin Lovastatin Pravastatin Fluvastatin High-Intensity (lowers LDL-C ≥ 50%) 63 40 mg ($196) 62 61 60 80mg ($9 gen, $ 236. br) 59 58 56 20 mg 54 ($196) 52
US-56427 ---------------------------- DOSAGE AND ...
den8dhaj6zs0e.cloudfront.netInitiate treatment with a 180 mg loading dose of BRILINTA then continue with 90 mg twice daily for up to 30 days. (2.3) Use BRILINTA with a daily maintenance dose of aspirin of …
Select Drug Formulary - AmeriHealth
www.amerihealth.comLow-to-moderate dose statin for prevention of cardiovascular disease, recommended for ages 40-75 years without a history of CVD when 1 or more CVD risk factors are present (e.g., dyslipidemia, diabetes, hypertension, or smoking) and a calculated 10-year risk of a cardiovascular event of 10% or greater lovastatin 10mg lovastatin 20mg lovastatin 40mg
Health Care Reform Preventive Services Coding Guide
www.bluecrossnc.com(Low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectal cancer (CRC) in adults aged 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years.)
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euDose dependent increases in blood lipid parameters were reported in patients treated with baricitinib (see section 4.8). Elevations in low density lipoprotein (LDL) cholesterol decreased to pre-treatment levels in response to statin therapy. Lipid parameters should be assessed approximately 12 weeks
Product, Summary, Dose, Characteristics, Summary of product characteristics, Statins
2021 HEDIS® Provider Pocket Guide COMMERCIAL/MEDICARE
www.healthnet.comStatin Therapy for Patients with Cardiovascular Disease (SPC) 84 Care Coordination Transitions of Care 95 Addendum ... the type/dose of medication, if needed. Outreach to patients at risk of noncompliance (missing at least 1 reill) via phone calls, medication prompts, or case management. 7 :